Solid Biosciences Inc.

SLDB

US83422E2046

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2024 am IST			5-day change	1st Jan Change
8.91 ^USD	-7.57%		+27.10%	+45.11%

16/07	North American Morning Briefing : Retail Sales, -2-	DJ
15/07	Solid Biosciences Shares Rise After JPMorgan Upgrade	MT

Solid Biosciences, LLC(NasdaqGS:SLDB) added to NASDAQ Composite Index

January 29, 2018 at 10:30 am IST

Solid Biosciences, LLC has been added to NASDAQ Composite Index .

Latest news about Solid Biosciences Inc.

North American Morning Briefing : Retail Sales, -2-	16/07	DJ
Solid Biosciences Shares Rise After JPMorgan Upgrade	16/07	MT
JPMorgan Upgrades Solid Biosciences to Overweight From Neutral, Adjusts Price Target to $15 From $10	15/07	MT
Solid Biosciences Joins Russell 3000 Index	01/07	MT
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell Small Cap Comp Value Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell Small Cap Completeness Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 3000 Value Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2000 Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 3000E Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 3000 Growth Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2500 Value Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell Microcap Growth Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2000 Value Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 3000E Growth Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2000 Growth Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2000 Dynamic Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2500 Growth Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell Small Cap Comp Growth Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 2500 Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 3000 Index	01/07	CI
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell 3000E Value Index	01/07	CI
Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12	24/06	MT
Top Premarket Gainers	21/06	MT
Solid Biosciences Inc. Announces Board Resignations	12/06	CI
Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI

Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and additional assets for the treatment of fatal cardiac diseases. The Company also has two cardiac pipeline gene transfer programs, SGT-601 for TNNT2 DCM and SGT-701 for RBM20 DCM, that are both in early preclinical development. It also has a neuromuscular gene transfer program for the treatment of Friedreich's ataxia. In addition to its gene transfer candidates, the Company has development programs focusing on platform technologies, including novel capsid libraries and dual gene expression, a technology that allows it to package multiple transgenes into one capsid.

Sector

Biotechnology & Medical Research

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.91 USD

Average target price

19.78 USD

Spread / Average Target

+121.97%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
SOLID BIOSCIENCES INC.	+45.11%	34Cr
VERTEX PHARMACEUTICALS INCORPORATED	+20.03%	13TCr
REGENERON PHARMACEUTICALS, INC.	+23.61%	12TCr
ARGENX SE	+22.53%	2.75TCr
BIONTECH SE	-18.07%	2.09TCr
GENMAB A/S	-15.24%	1.7TCr
BEIGENE, LTD.	-14.81%	1.63TCr
NEUROCRINE BIOSCIENCES, INC.	+9.78%	1.46TCr
WUXI APPTEC CO., LTD.	-46.10%	1.51TCr
SAREPTA THERAPEUTICS, INC.	+52.34%	1.39TCr

Bio Therapeutic Drugs

Solid Biosciences Inc.

Equities

SLDB

US83422E2046

Biotechnology & Medical Research

Solid Biosciences, LLC(NasdaqGS:SLDB) added to NASDAQ Composite Index

Latest news about Solid Biosciences Inc.

Chart Solid Biosciences Inc.

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs